Revenue: As of FY2025, the actual value is USD 6.534 M.EPS: As of FY2025, the actual value is USD -2.13.EBIT: As of FY2025, the actual value is USD -10.78 M.<h3>Health Solutions Segment</h3><ul><li>Revenue: The Health Solutions segment did not generate material revenue in the current period as it is classified as discontinued operations following the bankruptcy and wind-down of SRx Canada.</li><li>Operational Metrics: The segment faced financial difficulties leading to bankruptcy, resulting in the termination and wind-down of operations. Historical financial results are reported separately as discontinued operations.</li></ul><h3>Consumer Products Segment</h3><ul><li>Revenue: The Consumer Products segment generated net sales of $6.5 million for the year ended September 30, 2025, primarily from the sale of premium and super-premium pet food and wellness products.</li><li>Operational Metrics: Gross profit for the segment was $1.5 million, with a gross margin of 23%. Operating expenses totaled $12.9 million, leading to a loss from continuing operations of $11.4 million.</li><li>Cash Flow: Cash used in operating activities was $8.1 million, while cash provided by investing activities was $5.9 million, primarily due to cash acquired in business combinations. Financing activities provided $12.2 million, mainly from net proceeds of a PIPE offering and convertible debt issuance.</li></ul><h3>Outlook / Guidance</h3><ul><li>The Company is focused on stabilizing the remaining operations, optimizing cost structure, and re-establishing a focused growth path that aligns with the capabilities and market positioning of the Consumer Products business. Management believes that the streamlined business provides a clearer path to operational stability and disciplined execution.</li></ul>

SRX Health Solutions | 10-K: FY2025 Revenue: USD 6.534 M